Pentosan associated retinal pigmentary changes: FDA ’s perspective on an emerging postmarketing safety finding

ConclusionHere, we provide our perspective on the available evidence the agency weighed when retinal pigmentary changes were added to pentosan labeling. It is important for urogynecologists prescribing pentosan to be aware of this potential association and be vigilant about assessing eye health in pentosan users.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research